Dimitris Chatzis
Adjunct Assistant Professor, Cardiology
N/A
N/A
School of Medicine
Medicine
Academic Qualifications
| Qualification | Year | Awarding Institution | Department | Thesis title (Optional Entry) |
| PhD | 2010 | National and Kapodistrian University of Athens, Greece | Medicine | Diastolic dysfunction estimation in hypertensive patients with TDI: Correlations with great artery stiffness and BNP plasma levels |
| Medical Degree | 1999 | National and Kapodistrian University of Athens, Greece | Medicine | |
| Post Graduate Certificate | 2009 | Institute for Therapy Advancement (ITA), Paris, France | Interventional Cardiology |
Employment History
| Period of employment | Employer | Location | Position | |
| From | To | |||
| 9/2018 | 4/2022 | European University Cyprus | Nicosia, Cyprus | Scientific Collaborator |
| 10/2002 | 10/2009 | Hypertension Unit, 1st Cardiology Clinic, NKUA | Athens, Greece | Scientific Collaborator |
Publications
| Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
| 2022 | Role of diabetes in stroke: Recent advances in pathophysiology and clinical management | Sian A Bradley, Kevin J Spring, Roy G Beran, Dimitrios Chatzis, Murray C Killingsworth, Sonu M M Bhaskar | Diabetes Metab Res Rev . | 38(2) | e3495 |
| 2021 | Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes | Dimitrios G Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, Stefanos Chatzidakis , Konstantinos Avramidis, Marianna Leopoulou, Theodoros P Angelopoulos, John Doupis | Touch REV Endocrinol | 7(2) | 92-101. |
| 2021 | Critical emergency medicine and the resuscitative care unit | Mermiri M, Mavrovounis G, Chatzis D, Mpoutsikos I, Tsaroucha A, Dova M, Angelopoulou Z, Ragias D, Chalkias A, Pantazopoulos I | Acute Crit Care | 36(1) | 22-28 |
| 2020 | Peripherally Inserted Central Catheter lines for Intensive Care Unit and onco-hematologic patients: A systematic review and meta-analysis | Mavrovounis G, Mermiri M, Chatzis DG, Pantazopoulos I | Heart Lung | 49(6) | 922-933 |
| 2020 | COVID-19 pandemic and cardiovascular disease: where do we stand? | Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP | Minerva Cardioangiol. | 68(4) | 347-358 |
Exhibitions
| Date | Topic | International / Local | Location* | Role in Exhibition |
| 2022 | Management of hypertension in the old and very elderly patients | 6th School of Hypertension | Athens, GR | Instructor |
| 2021 | Management of patients with heart failure and renal failure | Panhellenic congress of cardiometabolic risk factors, obesity and diabetes | Lefkas, GR | Invited speaker |
| 2021 | Management of hypertension in the elderly population | 5th School of Hypertension | Athens, GR | Instructor |
| 2020 | How to treat Atrial Fibrillation | 2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION | Chalkidiki, GR | Moderator |
| 2018 | Anticoagulant therapy in high risk patients with atrial fibrillation | 2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION | Chalkidiki, GR | Invited speaker |
Research Projects
| Date | Title | Funded by | Project Role* |
| 2016 | PAVE – AF (Pattern of Antithrombotic therapy in Very Elderly patients with Atrial Fibrillation) non – interventional multicenter Greek study. | Pfizer Ltd | Lead Clinician |
| 2014 | TIGREECE multicenter national trial regarding the long term outcomes of Greek patients one year after myocardial infarction | Astra Zeneca Ltd | Principal Investigator |
| 2022 | DEFINE - AF (DEtection of atrial FIbrillatioN in Elderly hypertensive pAtients with leFt atrial enlargement in Greece) | Pfizer Ltd | Principal Investigator and Private practice cardiologists’ coordinator |
| 2010 | VALENTINES TRIAL (multicenter international trial regarding the effectiveness of the drug – eluting balloon Dior in the treatment of in stent restenosis | EuroCor | Research Team member |
| 2008 | ROCKET AF (Rivaroxaban Once daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation | Bayer Ltd | Research Team member |
Academic Consulting Services/Councils/Boards/Editorial Committees
| Period | Organization | Title of Position or Service |
| 11/2016 – 01/2019 | Pfizer Ltd | Senior Medical Advisor |
Awards/International Recognition
| Date | Title | Awarded by: |
| 2015 | Clinical Hypertension Specialist | European Society of Hypertension |
| 2015 | Full registration with license to practice in the specialist doctors list | General Medical Council (GMC), U.K. |
| 2022 | Referee, ESH congress 2022, Athens, GR | European Society of Hypertension |